BioKier Competitors and Similar CompaniesClear all
BioKier's competitors and similar companies include MannKind Corporation, Antag Therapeutics, Metabolic Solutions Development and Kadimastem.
 BioKier BioKier is a clinical-stage medical food and pharmaceutical company that develops drugs for diabetes and related disorders. |  MannKind Corporation MannKind Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products for patients. |  Antag Therapeutics Antag Therapeutics is a preclinical-stage biotechnology company focused on developing therapies for dietary-related metabolic diseases. |  Metabolic Solutions Development Metabolic Solutions Development Company (MSDC) is a company that discovers and develops molecular targets to treat metabolic diseases. |  Kadimastem Kadimastem is a biopharmaceutical company that develops industrial regenerative medicine therapies based on differentiated cells derived from human embryonic stem cells (hESCs). | |
Founding Date | Founding Date 2008 | Founding Date 1991 | Founding Date 2017 | Founding Date 2006 | Founding Date 2009 |
Type | Type Private | Type Public | Type Subsidiary | Type Private | Type Public |
Tags | |||||
Locations | Locations Chapel Hill, US HQ | Locations Westlake Village, US HQ Danbury, US | Locations København, DK HQ | Locations Kalamazoo, US HQ | Locations Ness Ziona, IL HQ |
Employees | Employees 5 | Employees 39513% increase | Employees 20 | Employees 13 | Employees 11 |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $349m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods $26.8m (FY, 2025) | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $322.2m (FY, 2025) | Gross profit (kr13.1m) (FY, 2021) | Gross profit N/A | Gross profit N/A |
Net income | Net income N/A | Net income $5.9m (FY, 2025) | Net income (kr14.9m) (FY, 2021) | Net income N/A | Net income (₪26.6m) (FY, 2024) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 200m | Total funding raised N/A | Total funding raised $ 42.2m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
MannKind Corporation
HQ
Westlake Village, US
Employees
395↑ 13% increase
MannKind Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products for patients.
View companyAntag Therapeutics
HQ
København, DK
Antag Therapeutics is a preclinical-stage biotechnology company focused on developing therapies for dietary-related metabolic diseases.
View companyMetabolic Solutions Development
HQ
Kalamazoo, US
Employees
13
Metabolic Solutions Development Company (MSDC) is a company that discovers and develops molecular targets to treat metabolic diseases.
View companyKadimastem
HQ
Ness Ziona, IL
Employees
11
Kadimastem is a biopharmaceutical company that develops industrial regenerative medicine therapies based on differentiated cells derived from human embryonic stem cells (hESCs).
View company